Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Titel:
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Auteur:
Spierings, Egilius LH Brandes, Jan Lewis Kudrow, David B Weintraub, James Schmidt, Peter C Kellerman, Donald J Tepper, Stewart J